NEW YORK, Nov. 21 (GenomeWeb News) - CytRx announced today that its subsidiary Araios, based in Worcester, Mass., will collaborate with 3rd Millennium to establish an informatics platform for RNAi-based drug development in the areas of type II diabetes and obesity.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.